ClinicalTrials.Veeva

Menu

Transcutaneous Posterior Nerve Stimulation inTreatment of Fecal Incontience

B

Batterjee Medical College

Status

Completed

Conditions

Fecal Incontinence

Treatments

Device: Sham Transcutanous Posterior Tibial Nerve Stimulation
Device: Transcutanous Posterior Tibial Nerve Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04478799
Banha University

Details and patient eligibility

About

Shafik and colleagues were the first to report the use of posterior tibial nerve stimulation (PTNS) for FI, and they documented improved continence after 4 weeks course. Subsequent studies documented percutaneous and transcutaneous PTNS as effective methods for treatment of FI, with a short term reduction in incontinence episode by 50-80 %. Percutaneous PTNS (PPTNS) showed a greater effect than transcutaneous PTNS (TPTNS) and this may be assumed due to the presence of the stimulating electrode very close to the posterior tibial nerve. However, TPTNS is more preferable to percutaneous PTNS because of the concern about the insertion of a needle may result in stimulation that is sufficient to produce a neuromodulatory effect.

Full description

Treatment of FNRFI is often difficult and requires prolonged therapies with unexpected responses and frequent relapses. The corner-stones in treatment of FNRFI are education, positive motivation, and toilet training. Preparation of children and their parents for a long-lasting treatment is mandatory with the expectation of many ups and downs. The main goal is to have regular bowel movements and normal continence and this can be achieved by teaching the child the importance of regular toilet use and avoid urges.

Many previous studies, reported the short term effect of TPTNS in treatment of FNRFI. However, there are sufficient studies evaluating the long term effect of TPNS and this has motivated the authors to conduct of this study The aim of this study is to evaluate the Long term outcome and quality of life in children with Functional non-retentive fecal incontinence and received Bilateral Transcutaneous posterior tibial nerve stimulation therapy.

Enrollment

102 patients

Sex

All

Ages

6 to 14 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ranged from (6-14 years) with FNRFI with normal bowel habits
  • Children with normal defecation frequency and normal stool consistency
  • Children with incontinence score ranging from 8-22 according to Vaizey score

Exclusion criteria

  • Children who have traumatic sphincter injury.
  • Children who have Fecal impaction
  • Children who have Spinal diseases causing incontinence
  • Children who have Anorectal malformation
  • Children who were not cooperative

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

102 participants in 2 patient groups

Group A (Transcutanous Posterior Tibial Nerve Stimulation)
Experimental group
Description:
Patients belonging to the group A received Transcautanoues posterior tibial nerve stimulation plus diet and Kegel exercises
Treatment:
Device: Transcutanous Posterior Tibial Nerve Stimulation
Group B (Sham Control)
Sham Comparator group
Description:
Patients belonging to the group B received Sham Transcautanoues posterior tibial nerve stimulation plus diet and Kegel exercises
Treatment:
Device: Sham Transcutanous Posterior Tibial Nerve Stimulation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems